Summary
While the presence of hyperlipidaemia in glycogen storage disease (GSD) type Ia and Ib is generally accepted, few investigators have adequately assessed lipid profiles of GSD III in children, in whom the presence of hyperlipidaemia may be most prominent. We analysed the lipid profiles in 44 GSD III patients from 6 months to 30 years of age. Hypertriglyceridaemia and hypercholesterolaemia were common in children younger than 3 years of age. Hypertriglyceridaemia correlated negatively with age, and may reflect increased severity of hypoglycaemia in this younger population. The presence of hyperlipidaemia during childhood in these patients identifies another GSD population that could be at risk for early cardiovascular disease (CVD). Consequently, the outcome of clinical trials investigating the vascular effect of hyperlipidaemia in GSD applies to types other than GSD I.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bandsma RH, Prinsen BH, van der Velden MD, et al (2008) Increased de novo lipogenesis and delayed conversion of large VLDL into IDL particles contribute to hyperlipidemia in glycogen storage disease type 1a. Pediatr Res [Epub ahead of print] PMID: 18277936.
Geberhiwot T, Alger S, McKiernan P, et al (2007) Serum lipid and lipoprotein profile of patients with glycogen storage disease types I, III and IX. J Inherit Metab Dis 30(3): 406. doi:10.1007/s10545-007-0485-2.
Hershkovitz E, Donald A, Mullen M, et al (1999) Blood lipids and endothelial function in glycogen storage disease type III. J Inherit Metab Dis 22(8): 891–898. doi:10.1023/A:1005687323096.
Muhlhausen C, Schneppenheim R, Budde U (2005) Decreased plasma concentration of von Willebrand factor antigen (vWF:Ag) in patients with glycogen storage disease type 1a. J Inherit Metab Dis 28: 945–950. doi:10.1007/s10545-005-0184-9.
Nguyen AD, Pan CJ, Weinstein DA (2006) Increased scavenger receptor class B type 1-mediated cellular cholesterol efflux and antioxidant capacity in the sera of glycogen storage disease type 1a patients. Mol Genet Metab 89(3): 233–238. doi:10.1016/j.ymgme.2006.05.002.
Ubels FL, Rake JP, Slaets JP (2002) Is glycogen storage disease 1a associated with atherosclerosis? Eur J Pediatr 161: s62–s64.
Wittenstein B, Klein M, Finckh B, Ullrich K, Kohlschutter A (2002) Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia. Free Radic Biol Med 33(1): 103–110. doi:10.1016/S0891-5849(02)00863-8.
Wolfsdorf JI, Weinstein DA (2003) Glycogen storage diseases. Rev Endocr Metab Disord 4(1): 95–102. doi:10.1023/A:1021831621210.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicating editor: Robert Steiner
Competing interests: None declared
References to electronic databases: Glycogen storage disease type III : OMIM 232400.
Rights and permissions
About this article
Cite this article
Bernier, A.V., Sentner, C.P., Correia, C.E. et al. Hyperlipidemia in glycogen storage disease type III: Effect of age and metabolic control. J Inherit Metab Dis 31, 729–732 (2008). https://doi.org/10.1007/s10545-008-0919-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-008-0919-5